ArticleBMB reports2022

DN200434, an orally available inverse agonist of estrogen-related receptor γ, induces ferroptosis in sorafenib-resistant hepatocellular carcinoma.

Dong-Ho Kim et al.PubMed ↗Full text ↗

No numbers read from the abstract.